user

LOW MOLECULAR WEIGHT HEPARIN DECREASES THE ALBUMINURIA AND RENAL PATHOLOGICAL CHANGES IN DIABETIC NEPHROPATHY RATS

被引：0
|
作者：
王锋 [1 ]
邢涛 [2 ]
汪年松 [1 ]
晏春根 [3 ]
机构：
[1] Department of Nephrology,the Sixth People's Hospital,Shanghai Jiaotong University
[2] Australian School of Advanced Medicine,Macquarie University
[3] Department of Internal Medicine,Hospital Affiliated to Medical College,Shaoxing College of Arts and Science
来源：
Medical Bulletin of Shanghai Jiaotong University | 2010年 / 22卷 / 02期
关键词：
diabetic nephropathy heparin P-selectin;
D O I：
暂无
中图分类号：
R587.2 [糖尿病性昏迷及其他并发症];
学科分类号：
1002 ; 100201 ;
摘要：
Objective To investigate the renoprotection effect of low molecular weight heparin(LMWH)in diabetic rats.Methods Diabetic rats were induced by injection of steptozotocin(STZ).Rats were randomly divided into three groups:control group,diabetic model group,and LMWH treatment group.The levels of total cholesterol(TC),triglyceride(TG),prothrombin time(PT),kaolin partial thromboplastin time(KPTT),24-hour urinary albumin excretion rate(UAER),and serum soluble P-selectin were determined after 8 weeks.Glomerular morphology was observed by light microscopy.Results The levels of TG,UAER,and P-selectin in LWMH treatment group were lower than those in model group(all P<0.01).The levels of PT and KPTT in LWMH treatment group were shorter than those in model group.And LWMH improved the histological changes of diabetic rats.Conclusion LMWH has some renal protective effects in diabetic rats,partly through down-regulating the expression of P-selectin.
引用
收藏
页码：66 / 70
页数：5
相关论文
共 50 条
  • [21] Low molecular weight Heparin in Patients with impaired Renal function
    Paar, W. D.
    Kaiser, J.
    von Stritzky, B.
    [J]. INTERNIST, 2012, 53 (12): : 1507 - 1508
  • [22] Efficacy and safety of low molecular weight heparin in renal transplantation
    Alkhunaizi, AM
    Olyaei, AJ
    Barry, JM
    deMattos, AM
    Conlin, MJ
    Lemmers, MJ
    Bennett, WM
    Norman, DJ
    [J]. TRANSPLANTATION, 1998, 66 (04) : 533 - 534
  • [23] Low-molecular-weight heparin in patients with renal insufficiency
    Schmid, Pirmin
    Fischer, Andreas G.
    Wuillemin, Walter A.
    [J]. SWISS MEDICAL WEEKLY, 2009, 139 (31-32) : 438 - 452
  • [24] No effect of unfractioned or low molecular weight heparin treatment on markers of vascular wall and hemostatic function in incipient diabetic nephropathy
    Myrup, B
    Jensen, T
    Gram, J
    Kluft, C
    Jespersen, J
    Deckert, T
    [J]. DIABETES CARE, 1997, 20 (10) : 1615 - 1619
  • [25] The influence of low molecular weight heparin on wound healing in rats
    Kus, Ewa
    [J]. MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2005, 4 (05): : 48 - 53
  • [26] Zinc supplementation partially prevents renal pathological changes in diabetic rats
    Tang, Yunan
    Yang, Qin
    Lu, Jiayin
    Zhang, Xiaolin
    Suen, Di
    Tan, Yi
    Jin, Litai
    Xiao, Jian
    Xie, Rujia
    Rane, Madhavi
    Li, Xiaokun
    Cai, Lu
    [J]. JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2010, 21 (03): : 237 - 246
  • [27] Low molecular weight age-peptides in diabetic nephropathy.
    Jerums, G
    Thomas, MC
    Cooper, ME
    [J]. DIABETOLOGIA, 2003, 46 : A343 - A343
  • [28] Low molecular weight fucoidan inhibits fibrotic processes in diabetic nephropathy
    Zhou, Hong
    [J]. BIOCHEMICAL PHARMACOLOGY, 2017, 139 : 115 - 116
  • [29] LOW-MOLECULAR WEIGHT PROTEINURIA IN DIABETIC CHILDREN - A MARKER OF EARLY DIABETIC NEPHROPATHY
    WARTHA, R
    GEKLE, D
    [J]. KIDNEY INTERNATIONAL, 1984, 26 (04) : 627 - 627
  • [30] A low-dose combination of valsartan and low molecular weight heparin better improved glomerular permeability than did high-dose monotherapy in rats with diabetic nephropathy
    Jiao, Bo
    Zhang, Yahui
    Cheng, Yanna
    Gao, Jianjun
    Zhang, Qingzhu
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2011, 5 (03): : 119 - 124
12345